Roxadustat as treatment for a blood transfusion-dependent maintenance hemodialysis patient: A case report and review of literature

Table 1 Baseline general information and clinical and laboratory characteristics

Characteristics
Age in yr	44
Sex	Male
Body weight in kg	60
Hb in g/L	49
SI in μmol/L	24.0
TIBC in μmol/L	51.6
TSAT, %	46.51
SF in ng/mL	656.03
iPTH in pg/mL	385
Dialysis method: hemodialysis/peritoneal dialysis	Hemodialysis
Duration of dialysis in yr	1.33
Dose of rhEPO injection in IU	6000
Frequency of rhEPO injection as times/wk	3
Blood pressure
Systolic in mmHg	157
Diastolic in mmHg	96
CRP in mg/L	4.61
Blood lipids
TC in mmol/L	3.76
TGs in mmol/L	5.19
LDL-C in mmol/L	0.74
HDL-C in mmol/L	2.43

CRP: C-reactive protein; EPO: Endogenous erythropoietin; Hb: Hemoglobin; HDL-C: High-density lipoprotein cholesterol; iPTH: Intact parathyroid hormone; LDL-C: Low-density lipoprotein cholesterol; rhEPO: recombinant human erythropoietin; SF: Serum ferritin; SI: Serum iron; TC: Total cholesterol; TG: Triglyceride; TIBC: Total iron-binding capacity; TSAT: Transferrin saturation.